Public Market Listing
GNFTEuronext Paris
Live quotes, historical charts, and market capitalization for Genfit are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(3 total)
3Total Assets
1Approved
0Phase 3 / Filed
2Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Elafibranor(Iqirvo) | Approved | PPAR-alpha/PPAR-deltaSmall molecule | Cholestatic Liver Disease Primary Biliary Cholangitis |
| Phase 1/2 | —Small molecule | Biliary Tract Cancer Cholangiocarcinoma with KRAS Mutation | |
| Preclinical / Unstaged | —Biologic (subtype unspecified) | Liver Failure Acute-on-Chronic Liver Failure |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.